DocGo’s (DCGO) “Buy” Rating Reiterated at Stifel Nicolaus

DocGo (NASDAQ:DCGO)‘s stock had its “buy” rating reiterated by equities research analysts at Stifel Nicolaus in a research report issued on Monday, Benzinga reports. They currently have a $12.00 price objective on the stock. Stifel Nicolaus’ price target would suggest a potential upside of 128.57% from the stock’s current price.

A number of other equities analysts have also recently weighed in on DCGO. Needham & Company LLC reissued a “buy” rating and issued a $14.00 price objective on shares of DocGo in a research report on Monday. Northland Securities raised their price objective on DocGo from $15.00 to $16.00 in a research note on Tuesday, August 8th. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $13.00 target price on shares of DocGo in a research report on Thursday. Finally, BTIG Research began coverage on shares of DocGo in a research report on Friday, August 18th. They set a “buy” rating and a $15.00 price target for the company.

DocGo Stock Down 7.9 %

Shares of DCGO stock traded down $0.45 during trading hours on Monday, reaching $5.25. The company had a trading volume of 2,336,038 shares, compared to its average volume of 745,437. The company has a market capitalization of $544.90 million, a P/E ratio of 75.00 and a beta of 0.85. The company has a debt-to-equity ratio of 0.01, a quick ratio of 2.56 and a current ratio of 2.56. DocGo has a twelve month low of $4.88 and a twelve month high of $11.41. The stock’s fifty day simple moving average is $8.68 and its 200 day simple moving average is $8.72.

DocGo (NASDAQ:DCGO) last issued its quarterly earnings data on Monday, August 7th. The company reported ($0.02) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.03 by ($0.05). The firm had revenue of $125.49 million during the quarter, compared to analyst estimates of $119.64 million. DocGo had a net margin of 1.27% and a return on equity of 3.20%. As a group, sell-side analysts expect that DocGo will post 0.09 earnings per share for the current fiscal year.

Insider Buying and Selling at DocGo

In other news, General Counsel Ely D. Tendler sold 10,000 shares of DocGo stock in a transaction that occurred on Tuesday, August 22nd. The stock was sold at an average price of $8.75, for a total value of $87,500.00. Following the completion of the transaction, the general counsel now owns 23,088 shares in the company, valued at approximately $202,020. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. In other news, General Counsel Ely D. Tendler sold 10,000 shares of the firm’s stock in a transaction dated Tuesday, August 22nd. The shares were sold at an average price of $8.75, for a total value of $87,500.00. Following the transaction, the general counsel now directly owns 23,088 shares in the company, valued at approximately $202,020. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, insider Adriaan Stephanus Oberholzer sold 50,000 shares of the business’s stock in a transaction dated Monday, August 14th. The shares were sold at an average price of $10.15, for a total transaction of $507,500.00. Following the sale, the insider now directly owns 1,193,413 shares of the company’s stock, valued at approximately $12,113,141.95. The disclosure for this sale can be found here. Insiders have sold 62,000 shares of company stock worth $613,000 over the last quarter. 13.78% of the stock is owned by corporate insiders.

Institutional Trading of DocGo

Several hedge funds have recently made changes to their positions in the stock. The Manufacturers Life Insurance Company grew its stake in DocGo by 3.7% during the 4th quarter. The Manufacturers Life Insurance Company now owns 31,603 shares of the company’s stock worth $223,000 after buying an additional 1,135 shares during the last quarter. Price T Rowe Associates Inc. MD increased its holdings in shares of DocGo by 8.1% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 15,617 shares of the company’s stock worth $136,000 after acquiring an additional 1,174 shares during the period. Legal & General Group Plc lifted its position in DocGo by 4.1% in the 4th quarter. Legal & General Group Plc now owns 33,116 shares of the company’s stock valued at $234,000 after purchasing an additional 1,303 shares during the last quarter. Victory Capital Management Inc. boosted its stake in DocGo by 6.3% during the 4th quarter. Victory Capital Management Inc. now owns 22,010 shares of the company’s stock valued at $220,000 after purchasing an additional 1,312 shares during the period. Finally, Bank of New York Mellon Corp grew its position in DocGo by 0.7% in the 2nd quarter. Bank of New York Mellon Corp now owns 308,152 shares of the company’s stock worth $2,887,000 after purchasing an additional 2,035 shares during the last quarter. Institutional investors own 52.14% of the company’s stock.

About DocGo

DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.